Abstract: The present invention discloses a prostate specific membrane antigen (PSMA) binding compound, a radioactive isotope complex thereof, and the use thereof in nuclear medicine as a tracer and an imaging agent for different disease states of prostate cancer.
Type:
Application
Filed:
April 13, 2021
Publication date:
October 6, 2022
Applicant:
SHANGHAI FO ZE MEDICAL TECHNOLOGY CO., LTD